McClellan Michael James

USNatural personCFO

Insider

McClellan Michael James

USNatural personCFO

Transactions

Issuers

Buys / Sells

0/6

Last tx

05 Nov 2019

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
TEVA PHARMACEUTICAL INDUSTRIES LTD	16,140.27	reported	05 Nov 2019	tx 24+231,294−12,228

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
05 Nov 2019	SALE	TEVA PHARMACEUTICAL INDUSTRIES LTD	242	8.83 USD
05 Nov 2019	EXERCISE	TEVA PHARMACEUTICAL INDUSTRIES LTD	695	—
05 Nov 2019	EXERCISE	TEVA PHARMACEUTICAL INDUSTRIES LTD	695	0.00 USD	deriv
18 Sept 2019	EXERCISE	TEVA PHARMACEUTICAL INDUSTRIES LTD	4,091	—
18 Sept 2019

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
TEVA PHARMACEUTICAL INDUSTRIES LTD	16,140.27	reported	05 Nov 2019	tx 24+231,294−12,228

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
05 Nov 2019	SALE	TEVA PHARMACEUTICAL INDUSTRIES LTD	242	8.83 USD
05 Nov 2019	EXERCISE	TEVA PHARMACEUTICAL INDUSTRIES LTD	695	—
05 Nov 2019	EXERCISE	TEVA PHARMACEUTICAL INDUSTRIES LTD	695	0.00 USD	deriv
18 Sept 2019	EXERCISE	TEVA PHARMACEUTICAL INDUSTRIES LTD	4,091	—
18 Sept 2019